hyperglycemic clamp
hyperglycemic clamp is an intervention with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
55.6%
5 of 9 finished
44.4%
4 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Role of Endocannabinoids in Insulin Production and Action
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Regulation of Insulin Secretion by the GLP-1 Receptor
Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp
Clinical Trials (11)
The Role of Endocannabinoids in Insulin Production and Action
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Regulation of Insulin Secretion by the GLP-1 Receptor
Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes
Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
Type 2 Diabetes and the Brain in Adolescents
Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome
Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis
GLP-1 Effects on Insulin and Glucagon in PTDM
The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP
All 11 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 11